Protease inhibitors linked to drop in CMV retinitis.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics; D018791:CD4 Lymphocyte Count; D017726:Cytomegalovirus Retinitis / Q000150:complications* / Q000188:drug therapy* / Q000517:prevention & control; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000008:administration & dosage / Q000191:economics; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D015774:Ganciclovir